✦ LIBER ✦

The PROactive study: Pioglitazone in the secondary prevention of macrovascular events in patients with type 2 diabetes

✍ Scribed by Richard E. Pratley

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The insulin sensitiser pioglitazone does

✍ J. E. Tooke; L. M. Elston; K. M. Gooding; C. I. Ball; D. M. Mawson; J. Piper; R. 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 114 KB

A prospective study of depression and mo

✍ D. G. Bruce; W. A. Davis; S. E. Starkstein; T. M. E. Davis 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 139 KB

The predictive value of TNF-α and IL-6 a

✍ Weihua Wu; Mingli Wang; Zhenjie Sun; Xin Wang; Jiajing Miao; Zhaohui Zheng 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 257 KB

Determinants of urinary albumin excretio

✍ E. Ritz; G. C. Viberti; L. M. Ruilope; A. J. Rabelink; J. L. Izzo; S. Katayama; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 163 KB

Pioglitazone reduces urinary albumin exc

✍ Akizuki Morikawa; Kanaki Ishizeki; Yasunori Iwashima; Hiroki Yokoyama; Eiji Muto 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 244 KB

Effects of fenofibrate on renal function

✍ T. M. E. Davis; R. Ting; J. D. Best; M. W. Donoghoe; P. L. Drury; D. R. Sullivan 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 320 KB